FASE AGUDA FASE CRÔNICA AIDS
8. CONSIDERAÇÕES FINAIS
Esse estudo confirmou a importância da análise dessas populações celulares e de moléculas associadas à ativação, diferenciação celular e senescência replicativa como importantes parâmetros imunológicos no acompanhamento de pacientes coinfectados. A continuação desses estudos frente ao estímulo específico poderá auxiliar a entender o papel desses parâmetros imunológicos no prognóstico da associação Leishmania/HIV.
78 9. REFERÊNCIAS
ALEXANDRINO-DE-OLIVEIRA P, SANTOS-OLIVEIRA JR, DORVAL ME, DA-COSTA FD, PEREIRA GR, DA CUNHA RV, PANIAGO AM, DA-CRUZ AM. HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil. Mem Inst Oswaldo Cruz 105(5):692-7, 2010.
ALVAR J, CAÑAVATE C, GUTIERREZ-SOLAR B, JIMENEZ M, LAGUNA F, LOPEZ- VELEZ R, MOLINA R, MORENO J. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Review 10: 298-319, 1997.
ALVAR J, APARICIO P, ASEFFA A, DEN BOER M, CAÑAVATE C, DEDET JP, GRADONI
L, TER HORST R, LÓPEZ-VÉLEZ R, MORENO J. The relationship
between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 21(2):334-59, 2008.
ALVAR J, VÉLEZ ID, BERN C, HERRERO M, DESJEUX P, CANO J, JANNIN J, DEN BOER M. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7(5):e35671, 2012.
ALVAR, J.; VÉLEZ, I. D.; BERN, C.; HERRERO, M.; DESJEUX, P.; CANO, J.; JANNIN, J.; DEN BOER, M.; WHO, Leishmaniasis Control Team. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7(5):e35671, 2012.
ANTINORI S, CALATTINI S, LONGHI E, BESTETTI G, PIOLINI R, MAGNI C, ORLANDO G, GRAMICCIA M, ACQUAVIVA V, FOSCHI A, CORVASCE S, COLOMBA C, TITONE L, PARRAVICINI C, CASCIO A, CORBELLINO M. Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature. Clin Infect Dis 44(12):1602-10, 2007.
APPAY V, ALMEIDA JR, SAUCE D, AUTRAN B, PAPAGNO L.
Accelerated immune senescence and HIV-1 infection Exp Gerontol 42(5):432-7, 2007.
APPAY V, ROWLAND-JONES SL. Premature ageing of the immune system:
the cause of AIDS? Trends Immunol 23(12):580-5, 2002.
APPAY V, SAUCE D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 214(2):231-41, 2008.
79
BARATA, R. A.; PEIXOTO, J.C.; TANURE, A.; GOMES, M. E.; APOLINÁRIO, E. C.; BODEVAN, E. C.; DE ARAÚJO, H. S.; DIAS, E. S.; PINHEIRO ADA, C. Epidemiology of visceral leishmaniasis in a reemerging focus of intense transmission in Minas Gerais State, Brazil. Biomed Res Int 2013:405083, 2013.
BARRÉ-SINOUSSI F, CHERMANN JC, REY F, NUGEYRE MT, CHAMARET S, GRUEST J, DAUGUET C, AXLER-BLIN C, VÉZINET-BRUN F, ROUZIOUX C,ROZENBAUM W, MONTAGNIER L. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220(4599):868-71, 1983.
BARRETO DE SOUZA V, PACHECO GJ, SILVA AR, CASTRO-FARIA-NETO HC, BOZZA PT, SARAIVA EM, BOU-HABBIB DC. Increased Leishmania replication in HIV-1-infected macrophages is mediated by tat protein through cyclooxygenase-2 expression and prostaglandin E2 synthesis. J Infect Dis 194(6): 846-54, 2006.
BARTOVSKÁ Z, BERAN O, ROZSYPAL H, HOLUB M. Antiretroviral treatment of HIV infection does not influence HIV-specific immunity but has an impact on non-specific immune activation. Curr HIV Res 9(2):88-94, 2011.
BELO VS, WERNECK GL, BARBOSA DS, SIMÕES TC, NASCIMENTO BW, DA SILVA ES, STRUCHINER CJ. Factors associated with visceral leishmaniasis in the americas: a systematic review and meta-analysis. PLoS Negl Trop Dis 7(4):e2182, 2013.
BENITO JM, LOPEZ M, LOZANO S, MARTINEZ P, GONZALEZ-LAHOZ J, SORIANO V. CD38 expression on CD8+ T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy. AIDS Res Hum Retroviruses 20(2):227- 33, 2004.
BENITO JM, ZABAY JM, GIL J, BERMEJO M, ESCUDERO A, SANCHEZ E, FERNANDEZ-CRUZ E. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in assymptomatic HIV infection: changes ithe expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens. J Acquir Immune Defic Syndr Hum Retrovirol 14(2): 128-135, 1997.
BENTWICH Z, KALINKOVICH A, WEISMAN Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 16(4):187-91, 1995.
BERHE N, WOLDAY D, HAILU A, ABRAHAM Y, ALI A, GEBRE-MICHAEL T, DESJEUX P, SÖNNERBORG A, AKUFFO H, BRITTON S. HIV viral load and response to antileishmanial chemotherapy in co-infected patients. AIDS 13(14):1921-5, 1999.
80
BERNIER R, BARBEAU B, TREMBLAY MJ, OLIVIER M. The lypophosphoglycan of
Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor-kB
elements. J Immunol 160(6):2881-8, 1998.
BHATTACHARYA P, ALI N. Involvement and interactions of different immune cells and their cytokines in human visceral leishmaniasis. Rev Soc Bras Med Trop 46(2):128-34, 2013.
BHATTACHARYA P, ALI N. Involvement and interactions of different immune cells and their cytokines in human visceralleishmaniasis. Rev Soc Bras Med Trop 46(2):128-34. 2013.
BOFILL M, MOCROFT A, LIPMAN M, MEDINA E, BORTHWICK NJ, SABIN CA, TIMMS A, WINTER M, BAPTISTA L, JOHNSON MA, LEE CA, PHILLIPS AN, JANOSSY G. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-infected patients. AIDS 10(8): 827-34, 1996.
BRENCHLEY JM, PRICE DA, SCHACKER TW, ASHER TE, SILVESTRI G, RAO S, KAZZAZ Z, BORNSTEIN E, LAMBOTTE O, ALTMANN D, BLAZAR BR,RODRIGUEZ
B, TEIXEIRA-JOHNSON L, LANDAY A, MARTIN JN, HECHT FM, PICKER
LJ, LEDERMAN MM, DEEKS SG, DOUEK DC. Microbial translocation is
a cause of systemic immune activation in chronic HIV infection. Nat Med 12(12):1365-71, 2006.
BRENCHLEY JM, DOUEK DC. The mucosal barrier and immune activation in HIV pathogenesis. Curr Opin HIV AIDS 3(3):356-61, 2008.
BRENCHLEY JM, KARANDIKAR NJ, BETTS MR, AMBROZAK DR, HILL BJ, CROTTY LE, CASAZZA JP, KURUPPU J, MIGUELES SA, CONNORS M, ROEDERER M, DOUEK DC, KOUP RA. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101(7):2711-20, 2003.
CACOPARDO B, NIGRO L, PREISER W, FAMA A, SATARIANO MI, BRANER J, CELESIA BM, WEBER B, RUSSO R, DOERR HW. Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment. Trans R Soc Trop Med Hyg 90(4): 434-5, 1996.
CARVALHO EM, BACELLAR O, BROWNELL C, REGIS T, COFFMAN RL, REED SG. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J Immunol 152(12):5949-56, 1994.
CARVALHO EM, BADARÓ R, REED SG, JONES TC, JOHNSON WD JR. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J Clin Invest 76(6):2066-9, 1985.
81
CASADO JL, LOPEZ-VELEZ R, PINTADO V, QUEREDA C, ANTELA A, MORENO S. Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapy. Eur J Clin Microbiol Infect Dis 20(3):202-5, 2001.
CAVALCANTI AT, MEDEIROS Z, LOPES F, ANDRADE LD, FERREIRA VDE
M, MAGALHÃES V, MIRANDA-FILHO DDE B. Diagnosing visceral leishmaniasis and HIV/AIDS co-infection: a case series study in Pernambuco, Brazil. Rev Inst Med Trop Sao Paulo 54(1):43-7, 2012.
CENTRO PARA PREVENÇÃO E CONTROLE DE DOENÇAS, CDC, 1993. Disponível em World Wibe Web: <URL: http:// http://www.cdc.gov/mmwr/preview/mmwrhtml/0018871.htm>. Acesso em 22 de setembro de 2013.
CHAMPAGNE P, OGG GS, KING AS, KNABENHANS C, ELLEFSEN K, NOBILE M, APPAY V, RIZZARDI GP, FLEURY S, LIPP M, FÖRSTER R, ROWLAND-JONES S, SÉKALY RP, MCMICHAEL AJ, PANTALEO G. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410(6824):106-11, 2001.
CHATTOPADHYAY PK, BETTS MR, PRICE DA, GOSTICK E, HORTON H, ROEDERER M, DE ROSA SC. The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression. J Leukoc Biol 85(1):88-97, 2009.
CHOU JP, RAMIREZ CM, WU JE, EFFROS RB. Accelerated aging in HIV/AIDS: novel biomarkers of senescent human CD8+ T cells. PLoS One 8(5):e64702, 2013.
COORDENAÇÃO MUNICIPAL DE DST-AIDS. Protocolo de atendimento sindrômico das intercorrências clínicas em hiv-AIDS. Prefeitura Municipal de Belo Horizonte, 2012.
CORBEAU P, REYNES J. Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection. Blood 117(21):5582-90, 2011.
COSTA CH, WERNECK GL, COSTA DL, HOLANDA TA, AGUIAR GB, CARVALHO AS, CAVALCANTI JC, SANTOS LS. Is severe visceral leishmaniasis a systemic inflammatory response syndrome? A case control study. Rev Soc Bras Med Trop 43(4):386-92, 2010.
COTA GF, DE SOUSA MR, FEREGUETTI TO, RABELLO A. Efficacy of anti-
leishmania therapy in visceral leishmaniasis among HIV infected patients:asystematic review wit h indirect comparison. PLoS Negl Trop Dis 7(5):e2195, 2013.
82
COTA GF, DE SOUSA MR, RABELLO A. Predictors of visceral leishmaniasis relapse in HIV- infected patients: a systematic review. PLoS Negl Trop Dis 5(6):e1153, 2011.
CRUZ I, NIETO J, MORENO J, CAÑAVATE C, DESJEUX P, ALVAR J. Leishmania/HIV co- infections in the second decade. Indian J Med Res 123(3): 357-88, 2006.
CUPOLILLO E, MEDINA-ACOSTA E, NOYES H, MOMEN H, GRIMALDI G JR. A revised classification for Leishmania and Endotrypanum. Parasitol Today 16(4):142-4, 2000.
DA-CRUZ AM, MACHADO ES, MENEZES JA, RUTOWITSCH MS, COUTINHO SG. Cellular and humoral immune responses of a patient with American cutaneous leishmaniasis and AIDS. Trans R Soc Trop Med Hyg 86(5): 511-2, 1992.
DA-CRUZ AM, RODRIGUES AC, MATTOS M, OLIVEIRA-NETO MP, SABBAGA- AMATO V, POSADA MP, LINDOSO JA, GOTO H. Alterações imunopatológicas na co- infecção HIV-Leishmania. Rev Soc Bras Med Trop Suppl 3:75-9, 2006.
DEEKS SG, VERDIN E, MCCUNE JM. Immunosenescence and HIV. Curr Opin Immunol 24(4):501-6, 2012.
DEEKS SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 62:141-55, 2011.
DEL GIUDICE P, MARY-KRAUSE M, PRADIER C, GRABAR S, DELLAMONICA P, MARTY P, GASTAUT JA, COSTAGLIOLA D, ROSENTHAL E, THE CLINICAL GROUP OF THE FRENCH HOSPITAL DATABASE ON HIV. Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French Cohort of patients infected with human immunodeficiency virus. J Infect Dis 186(9):1366-70, 2002.
DESJEUX P, ALVAR J. Leishmania/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol 97: Suppl 1:3-15, 2003.
DESJEUX P. Leishmania and HIV in gridlock. WHO and UNAIDS, Geneva, WHO/CTD/LEISH/98.9 Add.1, 1998.
DION ML, POULIN JF, BORDI R, SYLVESTRE M, CORSINI R, KETTAF N, DALLOUL A, BOULASSEL MR, DEBRÉ P, ROUTY JP, GROSSMAN Z, SÉKALY RP, CHEYNIER R. HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity 21(6):757-68, 2004.
83
DOUEK DC, BRENCHLEY JM, BETTS MR, AMBROZAK DR, HILL BJ, OKAMOTO Y, CASAZZA JP, KURUPPU J, KUNSTMAN K, WOLINSKY S, GROSSMAN Z, DYBUL M, OXENIUS A, PRICE DA, CONNORS M, KOUP RA. HIV preferentially infects HIV-specific CD4 T cells. Nature 417(6884): 95-8, 2002.
DOUEK DC, ROEDERER M, KOUP RA. Emerging concepts in
the immunopathogenesis of AIDS. Annu Rev Med 60:471-84, 2009.
DOUEK DC. HIV disease progression: immune activation, microbes and leaky gut. Topics in HIV Med 15(4):114-7, 2007.
EGGENA MP, BARUGAHARE B, JONES N, OKELLO M, MUTALYA S, KITYO C, MUGYENYI P, CAO H. Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 174(7):4407-14, 2005.
ENGELMAN A., CHEREPANOV P. The structural biology of HIV-1: mechanistic and therapeutic insights. Nature Reviews Microbiology 10, 279-290, 2012.
FOCOSI D, BESTAGNO M, BURRONE O, PETRINI M. CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol 87(1):107-16, 2010.
GALLO RC, SALAHUDDIN SZ, POPOVIC M, SHEARER GM, KAPLAN M, HAYNES BF, PALKER TJ, REDFIELD R, OLESKE J, SAFAI B, ET AL. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 224(4648):500-3, 1984.
GAUTAM S, KUMAR R, SINGH N, SINGH AK, RAI M, SACKS D, SUNDAR S, NYLÉN S. CD8 T cell Exhaustion in Human Visceral Leishmaniasis. J Infect Dis. 1-10, 2013.
GIGLEY JP, BHADRA R, MORETTO MM, KHAN IA. T cell exhaustion in protozoan disease. Trends Parasitol 28(9):377-84, 2012.
GIORGI JV, HO HN, HIRJI K, CHOU CC, HULTIN LE, O'ROURKE S, PARK L, MARGOLICK JB, FERBAS J, PHAIR JP. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+CD38+CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group. J Infect Dis 170(4):775-81, 1994.
GIORGI JV, LYLES RH, MATUD JL, YAMASHITA TE, MELLORS JW, HULTIN LE, JAMIESON BD, MARGOLICK JB, RINALDO CR JR, PHAIR JP, DETELS R, MULTICENTER AIDS COHORT STUDY. Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr 29(4):346-55, 2002.
84
GOTO H, LINDOSO JA. Immunity and immunosuppression in experimental
visceral leishmaniasis. Braz J Med Biol Res 37(4):615-23, 2004.
GOTO H, PRIANTI MD. Immunoactivation and immunopathogeny during active visceral leishmaniasis. Rev Inst Med Trop Sao Paulo 51(5):241-6, 2009.
GOULDER PJ, WATKINS DI. HIV and SIV CTL escape: implications for vaccine design. Nat Rev Immunol 4(8):630-40, 2004.
GROSSMAN Z, MEIER-SCHELLERSHEIM M, PAUL WE, PICKER LJ. Pathogenesis of HIV infection: what the virus spare is as important as what it destroys. Nat Med 12(3):289-95, 2006.
GROTTO MT, PARDINI IMC. Biologia molecular do HIV-1 e genética da resistência humana à AIDS. Arq Ciênc Saúde 13(3):61-4, 2006.
HARE BC. Clinical Overview of HIV Disease. HIV InSite Knowledge Base Chapter, University of California, San Francisco, 2009. Disponível em World Wibe Web: <URL: http:// hivinsite.ucsf.edu/InSite?page=kb-03-01-01#S6.1X >. Acesso em 24 de setembro de 2013.
HAZENBERG MD, STUART JW, OTTO SA, BORLEFFS JC, BOUCHER CA, DE BOER RJ, MIEDEMA F, HAMANN D. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 95(1):249-55, 2000.
HOLADAY BJ. Role of CD8+ T cells in endogenous interleukin-10 secretion associated with visceral leishmaniasis. Mem Inst Oswaldo Cruz 95(2):217-20, 2000.
HUNT PW, CAO HL, MUZOORA C, SSEWANYANA I, BENNETT J, EMENYONU N, KEMBABAZI A, NEILANDS TB, BANGSBERG DR, DEEKS SG, MARTIN JN. Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV infected Ugandans initiating antiretroviral therapy. AIDS 25(17):2123-31, 2011.
HUNT PW, HATANO H, SINCLAIR E, LEE TH, BUSCH MP, MARTIN JN, MCCUNE
JM, DEEKS SG. HIV specific CD4+ T cells may contribute to viral
persistence in HIV controllers. Clin Infect Dis 52(5):681-7, 2011.
JAIN V, HARTOGENSIS W, BACCHETTI P, HUNT PW, HATANO H, SINCLAIR E, EPLING L, LEE TH, BUSCH MP, MCCUNE JM, PILCHER CD, HECHT FM, DEEKS SG. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis 208(8):1202-11, 2013.
85
KARIM R, MACK WJ, STILLER T, OPERSKALSKI E, FREDERICK T, LANDAY
A, YOUNG MA, TIEN PC, AUGENBRAUN M, STRICKLER HD, Kovacs A.
Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach. AIDS 27(9):1473-81, 2013.
KITCHEN CM, YEGHIAZARIAN L, HOH R, MCCUNE JM, SINCLAIR E, MARTIN JN, DEEKS SG. Immune activation, CD4+ T cell counts, and viremia exhibit oscillatory patterns over time in patients with highly resistant HIV infection. PLoS One 6(6):e21190, 2011.
LIU Z, CUMBERLAND WG, HULTIN LE, KAPLAN AH, DETELS R, GIORGI JV. CD8+ T
lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J Acquir Immune Defic Syndr Hum Retrovirol 18(4):332-40, 1998.
LOPEZ-VELEZ R, CASADO J, PINTADO V. Decline of a visceral leishmaniasis epidemic in HIV-infected patients after the introduction of highly active antiretroviral therapy (HAART). Clin Microbiol Infect 7(7):394-5, 2001.
MAIA-ELKHOURY AN, ALVES WA, SOUSA-GOMES ML, SENA JM, LUNA EA. Visceral leishmaniasis in Brazil: trends and challenges. Cad Saude Publica, 24(12):2941-7, 2008.
MCCUNE JM. The dynamics of CD4+ T-cell depletion in HIV disease. Nature 410(6831):974-9, 2001.
MILLER V, MOCROFT A, REISS P, KATLAMA C, PAPADOPOULOS AI, KATZENSTEIN T, LUNZEN J, ANTUNES F, PHILLIPS AN, LUNDGREN JD. Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA Study. Ann Intern Med 130(7):570-7, 1999.
MINISTÉRIO DA SAÚDE/SECRETARIA DE VIGILÂNCIA EM SAÚDE. Programa Nacional de DST/HIV/Aids: Critérios de definição de casos de Aids em adultos e crianças. MS/SVS, Brasil, 2004.
MINISTÉRIO DA SAÚDE, 2013. História da AIDS. Disponível em World Wibe Web: <URL: http:// http://www.aids.gov.br/pagina/historia-da-aids> Acesso em 22 de setembro de 2013.
MINISTÉRIO DA SAÚDE, 2013. LEISHMANIOSE VISCERAL - Casos confirmados Notificados no Sistema de Informação de Agravos de Notificação - SINAN Net. Disponível em
86
WorldWibeWeb:<URL:http:// dtr2004.saude.gov.br/sinanweb/tabnet/dh?sinannet/leishvi/bases/l eishvbrnet.def> Acesso em 22 de setembro de 2013.
MINISTÉRIO DA SAÚDE. Boletim Epidemiológico de Leishmaniose visceral. MS/SVS, Rio Grande do Sul, 13: n. 1, 2011.
MINISTÉRIO DA SAÚDE. Manual de leishmanioses visceral. MS/SVS, Brasil, 2006.
MINISTÉRIO DA SAÚDE/SISTEMA DE VIGILÂNCIA EM SAÚDE, MS/SVS. AIDS no Brasil. Departamento de DST, Aids e Hepatites Virais, Brasil, 2012.
MINISTÉRIO DA SAÚDE/SISTEMA DE VIGILÂNCIA EM SAÚDE, MS/SVS. Boletim Epidemiológico de Leishmanioses. Brasil, 2013.
MINISTÉRIO DA SAÚDE/SISTEMA DE VIGILÂNCIA EM SAÚDE, MS/SVS. Boletim Epidemiológico HIV/AIDS. Brasil, Ano I, n°1, 2012.
MINISTÉRIO DA SAÚDE/SISTEMA DE VIGILÂNCIA EM SAÚDE, MS/SVS. Manual de recomendações para diagnóstico, tratamento e acompanhamento de pacientes com a coinfecção
Leishmania/HIV. Brasil, 2011.
MINISTÉRIO DA SAÚDE/SISTEMA DE VIGILÂNCIA EM SAÚDE, MS/SVS. Sistema de Informação de Agravos de Notificação. Brasil, 2010.
MIRA JA, CORZO JE, RIVERO A, MACIAS J, DE LEON FL, TORRE-CISNEROS J, GOMEZ-MATEOS J, JURADO R, PINEDA JA. Frequency of visceral leishmaniasis relapses in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. Am J Trop Med Hyg 70(3): 298-301, 2004.
MOCROFT A, VELLA S, BENFIELD TL, CHIESI A, MILLER V, GARGALIANOS P, D'ARMINIO MONFORTE A, YUST I, BRUUN JN, PHILLIPS AN, LUNDGREN JD. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 352(9142):1725-30, 1998.
MORROW CD, PARK J, WAKEFIELD JK. Viral gene products and replication of the human immunodeficiency type 1 virus. Am J Physiol 266(5 Pt 1):C1135-56, 1994.
NAUFAL SPIR PR, ZAMPIERI D'ANDREA LA, FONSECA ES, PRESTES-CARNEIRO LE. Epidemiology of human immunodeficiency virus-visceral leishmaniasis-co-infection. J Microbiol Immunol Infect 1182(13)00081-9, 2013.
87
ORGANIZAÇÃO MUNDIAL DE SAÚDE, 2012. Disponível em World Wibe Web: <URL: http:// www.who.int/leishmaniasis/epidemic/en/>. Acesso em 20 de setembro de 2013.
ORGANIZAÇÃO MUNDIAL DE SAÚDE, 2012. Media Center: HIV/AIDS Disponível em World Wibe Web: <URL: http:// www.who.int/mediacentre/factsheets/fs360/en/>. Acesso em 24 de setembro de 2013.
ORGANIZAÇÃO MUNDIAL DE SAÚDE, OMS. Global report: UNAIDS report on the global AIDS epidemic 2013, 2013.
ORGANIZAÇÃO MUNDIAL DE SAÚDE, OMS. Report of the Fifth Consultative Meeting on
Leishmania/HIV Coinfection, Ethiopia, 2007.
OSMAN OF, OSKAM L, ZIJLSTRA EE, EL-HASSAN AM, EL-NAEIM DA, KAGER PA. Use of the polymerase chain reaction to assess the success of visceral leishmaniasis treatment. Trans R Soc Trop Med Hyg 92(4):397-400, 1998.
PALMER BE, BLYVEIS N, FONTENOT AP, WILSON CC. Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell dysfunction. J Immunol 175(12):8415-23, 2005.
PANTALEO G, FAUCI AS. Immunopathogenesis of HIV infection. Annu Rev Microbiol 50:825-54, 1996.
PANTALEO G, FAUCI AS. Apoptosis in HIV infection. Nat Med 1(2):118-20, 1995.
PAPAGNO L, SPINA CA, MARCHANT A, SALIO M, RUFER N, LITTLE S, DONG
T, CHESNEY G, WATERS A, EASTERBROOK P, DUNBAR PR, SHEPHERD
D,CERUNDOLO V, EMERY V, GRIFFITHS P, CONLON C, MCMICHAEL AJ, RICHMAN DD, ROWLAND-JONES SL, APPAY V. Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol 2(2):E20, 2004.
PICKER LJ. Immunopathogenesis of acute AIDS virus infection. Curr Opin Immunol 18(4):399- 405, 2006.
PINZONE MR, DI ROSA M, CACOPARDO B, NUNNARI G. HIV RNA suppression and immune restoration: can we do better? Clin Dev Immunol 2012:515962, 2012.
POZIO E, MORALES MA. The impact of HIV-protease inhibitors on opportunistic parasites. Trends Parasitol 21(2):58-63, 2005.
88
PREISER W, CACOPARDO B, NIGRO L, BRANER J, NUNNARI A, DOERR HW, WEBER B. Immunological findings in HIV-Leishmania coinfection. Intervirology 39(4):285-8, 1996.
RAMALINGAM S, KANNANGAI R, ABRAHAM OC, SUBRAMANIAN S, RUPALI P, PULIMOOD SA, JESUDASON MV, SRIDHARAN G. Chemokine profile among human immunodeficiency virus-1 (HIV-1) infected individuals fromsouthern India. Indian J Med Res 127(2):133-9, 2008.
SAHA S, MONDAL S, BANERJEE A, GHOSE J, BHOWMICK S, ALI N. Immune responses in kala-azar. Indian J Med Res 123(3):245-66, 2006.
SANTOS-OLIVEIRA JR, DA-CRUZ AM, PIRES LH, CUPOLILLO E, KUHLS K, GIACOIA-
GRIPP CB, OLIVEIRA-NETO MP. Atypical lesions as a sign of cutaneous
dissemination of visceral leishmaniasis in a human immunodeficiency virus-positive patient simultaneously infected by two viscerotropic Leishmania species. Am J Trop Med Hyg. 85(1):55-9, 2011.
SANTOS-OLIVEIRA JR, DA-CRUZ AM. Lipopolysaccharide-Induced Cellular
Activation May Participate in the Immunopathogenesis ofVisceral Leishmaniasis Alone or in HIV Coinfection. Int J Microbiol 2012:364534, 2012.
SANTOS-OLIVEIRA JR, REGIS EG, GIACOIA-GRIPP CB, VALVERDE
JG, ALEXANDRINO-DE-OLIVEIRA P, LINDOSO JÂ, GOTO H, OLIVEIRA-NETO
MP,GUERRA JO, GRINSZTEJN B, JERÔNIMO SB, MORGADO MG, DA-CRUZ AM. Microbial translocation induces an intense proinflammatory response in patients with visceral leishmaniasis and HIV type 1 coinfection. J Infect Dis 208(1):57-66, 2013.
SANTOS-OLIVEIRA JR, GIACOIA-GRIPP CB, ALEXANDRINO DE OLIVEIRA
P, AMATO VS, LINDOSO JÂ, GOTO H, OLIVEIRA-NETO MP, MATTOS
MS,GRINSZTEJN B, MORGADO MG, DA-CRUZ AM. High levels of T lymphocyte activation in Leishmania-HIV-1 co-infected individuals despite low HIV viral load 10:358, 2010.
SAUCE D, LARSEN M, FASTENACKELS S, PAUCHARD M, AIT-MOHAND
H, SCHNEIDER L, GUIHOT A, BOUFASSA F, ZAUNDERS J, IGUERTSIRA M, BAILEY M, GOROCHOV G, DUVIVIER C, CARCELAIN G, KELLEHER AD, SIMON A, MEYER L, COSTAGLIOLA D, DEEKS SG, LAMBOTTE O, AUTRAN B, HUNT PW,KATLAMA C, APPAY V.HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis. Blood 117(19):5142-51, 2011.
SCOTT P. Immunologic memory in cutaneous leishmaniasis. Cell Microbiol 7(12):1707-13, 2005.
SHAW JJ. Taxonomy of the genus Leishmania: present and future trends and their implications. Mem Inst Oswaldo Cruz 89(3):471-8, 1994.
89
SINHA PK, BIMAL S, SINGH SK, PANDEY K, GANGOPADHYAY
DN, BHATTACHARYA SK. Pre- & post-treatment evaluation of immunological features in Indian visceral leishmaniasis (VL) patients with HIV co-infection. Indian J Med Res 123(3):197- 202, 2006.
SOUSA-GOMES ML, MAIA-ELKHOURY AN, PELISSARI DM, DE LIMA JUNIOR FE,